Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Pernille Wehn
The Prosigna Gene Expression Assay and Responsiveness to Adjuvant Cyclophosphamide-Based Chemotherapy in Premenopausal High-Risk Patients With Breast Cancer
Breast Cancer Research
Cancer Research
Oncology
Related publications
Development and Verification of the PAM50-based Prosigna Breast Cancer Gene Signature Assay
BMC Medical Genomics
Genetics
Fatigue and Relating Factors in High-Risk Breast Cancer Patients Treated With Adjuvant Standard or High-Dose Chemotherapy: A Longitudinal Study
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
P53 Expression Status Is Associated With Cancer-Specific Survival in Stage III and High-Risk Stage II Colorectal Cancer Patients Treated With Oxaliplatin-Based Adjuvant Chemotherapy
British Journal of Cancer
Cancer Research
Oncology
Maintaining Dose Intensity of Adjuvant Chemotherapy in Older Patients With Breast Cancer
Clinical Breast Cancer
Cancer Research
Oncology
High-Dose Chemotherapy in High-Risk Breast Cancer
Breast Cancer Research
Cancer Research
Oncology
Population-Based Study of the Effect of Gene Expression Profiling on Adjuvant Chemotherapy Use in Breast Cancer Patients Under the Age of 65 Years
Cancer
Cancer Research
Oncology
The Use of a Cognitive Protectant to Help Maintain Quality of Life and Cognition in Premenopausal Women With Breast Cancer Undergoing Adjuvant Chemotherapy
High Expression of Class III Β-Tubulin Predicts Good Response to Neoadjuvant Taxane and Doxorubicin/Cyclophosphamide-Based Chemotherapy in Estrogen Receptor–Negative Breast Cancer
Clinical Breast Cancer
Cancer Research
Oncology
Clinical Impact of Delaying Initiation of Adjuvant Chemotherapy in Patients With Breast Cancer
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
